Benjamin Edwards Inc’s Genmab GMAB Stock Holding History

Benjamin Edwards Inc’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,454	Closed	-$507K	–	1382
2025 Q4	$507K	Sell	16,454 -2,547	-13%	-$79.4K	0.01%	946
2025 Q3	$583K	Buy	+19,001	New	+$463K	0.01%	885

Other funds holding GMAB

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Benjamin Edwards Inc's GMAB Position: Q1 2026 in Review

Benjamin Edwards Inc sold out of Genmab (GMAB) in Q1 2026, closing a stake of 16,454 shares — an estimated $507K sold.

Benjamin Edwards Inc first reported a position in GMAB in Q3 2025 and held it in 2 quarters. The position peaked at $583K in Q3 2025. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

Benjamin Edwards Inc reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
Benjamin Edwards Inc sold 16,454 Genmab shares in Q1 2026, an estimated $507K.
Benjamin Edwards Inc first reported a position in Genmab in Q3 2025 and held it in 2 quarters.
Benjamin Edwards Inc's Genmab position peaked at $583K in Q3 2025.
274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Benjamin Edwards Inc's 13F filing for Q1 2026, filed 12 May 2026.